Frédéric Pouliot

16PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Site-based writingPharmacogenomicsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 12, 2026
Biomarkers for Precision Prognosis in Prostate Cancer: Imaging, Molecular, and Integrated Approaches.

|Apr 14, 2026
ANGPTL3, Apo CIII, Leptin and Triglycerides Are Elevated in Metastatic Prostate Cancer.

Gabriel Boulay, Marwan Khodr, Ann-Charlotte Bergeron

|Mar 27, 2026
Outcomes and Predictors of Recurrence and Survival in Surgically Resected Localized Chromophobe Renal Cell Carcinoma: Results from the Canadian Kidney Cancer Information System (CKCis).

Erica Arenovich, Rodney Breau, Ricardo Rendon

|Mar 04, 2026
131I-LNTH-1095 Radioligand Therapy plus Enzalutamide versus Enzalutamide Alone in Men with PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase II Study.

Evan Y Yu, Vivek Narayan, Giuseppe Esposito

|Feb 13, 2025
Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients.

Noa Shani Shrem, Ana-Alicia Beltran-Bless, Sunita Ghosh

|Aug 28, 2024
Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database.

Changsu Lawrence Park, Feras Ayman Moria, Sunita Ghosh

Pageof 3

Frequent Collaborators

4 joint publications

Aly-Khan A Lalani

3 joint publications

Lori Wood

2 joint publications

Dominick Bossé

2 joint publications

Simon Tanguay